Subsequent Events	3 Months Ended
Oct. 31, 2012
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 12 – Subsequent Events: On November 30, 2012, the Company’s subsidiary, Generex Pharmaceuticals Inc., entered in to an agreement with a private lender for a mortgage loan of $855,000 with an annual interest rate of 9.75% and a maturity date of November 30, 2013, secured by real estate owned by the subsidiary. The prior mortgage loan of $156,596 was discharged from the proceeds and the Company received approximately $620,000, after the prior mortgage discharge, legal expenses and other fees. The Company has evaluated subsequent events occurring after the balance sheet date through the date the interim consolidated financial statements were issued.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

No definition available.

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration